Recurrence of Hepatocellular Carcinoma

Completed

• Conditions: Hepatocellular Carcinoma

• Registration Number: NCT01520779
• Lead Sponsor: Ain Shams University

Brief Summary

analysis of the risk factors of intra-hepatic distant recurrence (IDR) of hepatocellular carcinoma within 1 year after radiofrequency ablation.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-01
• Study First Submitted: 2012-01-26
• Study First Submitted QC: 2012-01-26
• Study First Posted: 2012-01-30
• Primary Completion: 2012-11
• Study Completion: 2012-12
• Status Verified: 2013-09
• Last Update Submitted: 2013-09-29
• Last Update Posted: 2013-10-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 99

Inclusion Criteria

1. Proved diagnosis of HCC according to AASLD practice guidelines (Bruix and Sherman, 2005).
2. Patients underwent RFA for HCC with BCLC (The Barcelona-Clinic- Liver-Cancer staging system) stage A (Bruix and Sherman, 2005) with no eligibility or ability to do transplantation or resection.
3. Patients should be followed-up for more than 12 months to exclude early recurrence i.e. recurrence within 1 year.
4. Patients with INR < 1.5 or prothrombin concentration > 50%.
5. Platelet count > 50000 cell/mm3.

Read More

Exclusion Criteria

1. Presence of extra-hepatic metastasis or gross vascular invasion.
2. Child class C patients.
3. Follow up period of less than 12 months.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Recurrence of hepatocellular carcinoma	1 year

Trial Locations

Locations (1)

Tropical medicine department; 🇪🇬 Cairo, Egypt